Susceptibility in vitro of Helicobacter pylori to cetylpyridinium chloride

FEMS Immunology and Medical Microbiology

Volumn 24, Issue 2, 1999, Pages 189-192

  Bereswill, Stefan ^a   Vey, Tanja ^a   Kist, Manfred ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Antibiotic therapy; Helicobacter pylori; Resistance

Indexed keywords

ANTIINFECTIVE AGENT; CETYLPYRIDINIUM SALT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; DILUTION; ESCHERICHIA COLI; HELICOBACTER PYLORI; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUTH INFECTION; PHARYNGITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

EID: 0032947664     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00025-5     Document Type: Article

References (16)

1. Malfertheiner P., Megraud F., O'Morain C., Bell D., Porro G.P., Deltenre M., Forman D., et al. Current European concepts in the management of Helicobacter pylori infection - The Maastricht Consensus Report. Eur. J. Gastroenterol. Hepatol. 9:1997;1-2.
2. Mae F.G., Fennerty M.B. Treatment of Helicobacter pylori infections. Curr. Opin. Gastroenterol. 14:1998;64-69.
3. Buckley M.J.M., Xia H.-X., Hyde D.M., Keane C.T., O'Morain C.A. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance. Dig. Dis. Sci. 42:1997;2111-2115.
4. Huyek L.C. Cetylpyrimidinium chloride. Am. J. Pharm. 116:1944;50-59.
5. Irizarry L., Merlin T., Rupp J., Griffith J. Reduced susceptibility of methicillin-resistant Staphylococcus aureus to cetylpyridinium chloride and chlorhexidine. Chemotherapy. 42:1996;248-252.
6. Nakamoto K., Tamamoto M., Hamada T. In vitro effectiveness of mouthrinses against Candida albicans. Int. J. Prosthodont. 8:1995;486-489.
7. Renton-Harper P., Addy M., Moran J., Doherty F.M., Newcombe R.G. A comparison of chlorhexidine, cetylpyridinium chloride, triclosan, and C31G mouthrinse products for plaque inhibition. J. Periodontol. 67:1996;486-489.
8. Piccolomini R., Bonaventura G.D., Catamo G., Carbone F., Neri N. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J. Clin. Microbiol. 35:1997;1842-1846.
9. Hartzen S.H., Andersen L.P., Bremmelgaard A., Colding H., Arpi M., Kristiansen J., Justesen T., Espersen F., Frimodt-Moller N., Bonnevie O. Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time. Antimicrob. Agents Chemother. 41:1997;2634-2639.
10. Bereswill S., Fassbinder F., Voelzing C., Covacci A., Haas R., Kist M. Hemolytic properties and riboflavin synthesis of Helicobacter pylori: Cloning and functional characterization of the ribA gene encoding GTP-cyclohydrolase II that confers hemolytic activity to Escherichia coli. Med. Microbiol. Immunol. 186:1998;177-187.
11. Bereswill S., Waidner U., Odenbreit S., Lichte F., Fassbinder F., Bode G., Kist M. Structural functional and mutational analysis of the pfr gene encoding a ferritin from Helicobacter pylori. Microbiology. 144:1998;2505-2516.
12. Boyer H.W., Roulland Dussoix D. A complementation analysis of the restriction and modification of DNA in Escherichia coli. J. Mol. Biol. 41:1969;459-472.
13. Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment. Pharmacol. Ther. 11:(Suppl. 1):1997;43-53.
14. Henriksen T.H., Brorson Ö., Schöyen R., et al. Risks related to lack of standardization of tests to detect in vitro metronidazole resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 15:1996;484-488.
15. Bundesverband der Pharmazeutischen Industrie (1997) Rote Liste 1997. Editio Cantor Verlag, Aulendorf.
16. Adamsson I., Edlund C., Seensalu R., Sjöstedt S., Nord C.E. The normal gastric microflora and Helicobacter pylori: before, during and after treatment with omeprazole. Clin. Microbiol. Infect. 4:1998;308-315.